Classifying Medical Cannabis vs. Traditional Pharmaceuticals Guides Marketing Efforts September 3, 2019 John Taenzler Marketing, Medical Marijuana, Spotlight 0 Comments When considering Medical Cannabinoid Therapy (MCT), most informed physicians and patients focus on two classes of cannabinoids: tetrahydrocannabinols (THC) and cannabidiols (CBD). However, research has identified over 500 compounds in cannabis, including over 120 distinct cannabinoids and over 100 terpenes. Despite… Read More→
Legal Implications for Physicians Recommending Medical Cannabis in the USA July 17, 2019 John Taenzler Medical Marijuana 0 Comments In our studies examining the use of Medical Cannabis Therapy (MCT) by Oncologists and Pain Management Specialists[i], we asked physicians what their biggest barrier was to their adoption of medical cannabis. Two-thirds (65%), mention legal concerns. Concern for legal exposure… Read More→
Promoting Medical Cannabis Among Pain Patients in the USA June 13, 2019 John Taenzler Medical Marijuana 0 Comments John Taenzler, Ph.D. Of all the potential benefits of medical cannabis being explored, pain relief appears to hold the most immediate promise. A review by the National Institutes of Health (NIH) of the implications of pain on a patient’s life… Read More→
Promoting MMJ Among Pain Management Specialists in the USA May 9, 2019 John Taenzler Medical Marijuana 0 Comments By John Taenzler, Ph.D. Millions suffer from acute or chronic pain every year and the effects of pain exact a tremendous cost in terms health care costs, rehabilitation and lost worker productivity, as well as the emotional and financial burden… Read More→
Promoting MMJ Among Cancer Patients in the USA April 10, 2019 John Taenzler Marketing, Medical Marijuana 0 Comments John Taenzler, Ph.D. In October 2018, a survey was conducted among 92 patients currently being treated for cancer in 17 of the States where medical marijuana (MMJ) has been approved and available. An objective of this research was to assess… Read More→
Promoting MMJ Among Oncologist in the USA March 3, 2019 John Taenzler Cannabis & Hemp Research, Medical Marijuana 0 Comments By John Taenzler, Ph.D. In October 2018, a survey was conducted among 87 oncologists (ONCs) in 19 of the States where medical marijuana (MMJ) has been approved and available. An objective of this research was to assess the depth of… Read More→
Advances in MMJ: MJBizCon Las Vegas 2018 January 26, 2019 John Taenzler Medical Marijuana, Science and Technology 0 Comments Congratulation to MJBiz for a successful conference in Las Vegas. The turn-out was astounding. In the Key Note address, Torsten Keunzlen from SunDial, perfectly captured this time in the growth of MMJ as a legitimate treatment for a host of… Read More→
Big Pharma is Coming for the Cannabis Industry January 5, 2019 John Taenzler Medical Marijuana, Science and Technology 0 Comments In a recent double-blinded study [1] examining the attitudes of pain specialists and oncologists toward the use of MMJ, only 38% of these physicians in the USA are recommending MMJ to their patients for treating the symptoms of their disease and/or… Read More→
Perceptions of MMJ Among Pain Specialists in The USA November 8, 2018 John Taenzler Marketing, Medical Marijuana, Science and Technology 0 Comments By John Taenzler, Ph.D., Partner The following data was drawn from a survey of 86 Pain Management Specialists (APMs) in states where MMJ is legal. All data was collected using a double-blind protocol. Cannalytic Insights adheres to the CASRO Code… Read More→